Endometrial Neoplasms clinical trials at UCSF
1 in progress, 1 open to new patients
Phase 2 Study of MLN0128, Combination of MLN0128 With MLN1117, Paclitaxel and Combination of MLN0128 With Paclitaxel in Women With Endometrial Cancer
open to eligible females ages 18 years and up
The primary purpose of this study is to determine if MLN0128 in combination with weekly paclitaxel improves progression-free survival (PFS) compared to weekly paclitaxel alone.
San Francisco, California and other locations